Horizon Therapeutics PLC (NASDAQ:HZNP)

Delayed Data
As of 3:59pm ET
 +0.79 / +1.01%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 14 analysts offering 12-month price forecasts for Horizon Therapeutics PLC have a median target of 99.50, with a high estimate of 146.00 and a low estimate of 74.00. The median estimate represents a +26.29% increase from the last price of 78.79.

Analyst Recommendations

The current consensus among 14 polled investment analysts is to Buy stock in Horizon Therapeutics PLC. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -14.07%
Growthannually 1.82%


Growthquarterly -0.34%
Growthannually 11.78%
Key to the earnings and sales forecast charts.